skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8129

Risk reduction with clopidogrel in the management of peripheral arterial disease

(2231) Views  (434) Full article downloads

Authors: Keshav R Nayak, Jeffrey J Cavendish

Published Date August 2007 Volume 2007:3(3) Pages 289 - 297
DOI: http://dx.doi.org/10.2147/VHRM.S

Keshav R Nayak, Jeffrey J Cavendish

Department of Cardiology, Naval Medical Center San Diego, San Diego, CA, USA

Abstract: Peripheral arterial disease (PAD) is a condition typified by decreased arterial blood flow in the non-coronary branches of the aorta as a result of chronic atherosclerosis. Despite the higher prevalence of PAD compared with other cardiovascular entities such as myocardial infarction and stroke, far less import is given to its diagnosis and treatment. In this review, we highlight principal diagnostic and therapeutic considerations in the management of PAD and its complications. We particularly emphasize the role of clopidogrel in the reduction of risks associated with PAD.

Keywords: clopidogrel, antiplatelet therapy, peripheral artery disease
  • Join ISVH

    Be part of the World's leading experts in vascular health by joining the International Society of Vascular Health (ISVH)

  • Testimonials

    "... I was impressed at the rapidity of publication from submission to final acceptance." Dr Edwin Thrower, PhD, Yale University